Tech Company Financing Transactions
Health Catalyst Funding Round
On 2/28/2013, Health Catalyst secured $8 million in Series B funding from CHV Capital and Kaiser Permanente Ventures.
Transaction Overview
Company Name
Announced On
2/28/2013
Transaction Type
Venture Equity
Amount
$8,000,000
Round
Series B
Investors
CHV Capital (Kyle Salyers)
Proceeds Purpose
This latestfinancing bolsters Health Catalyst's ability to invest in development,services, and people to support its clients as well as strengthen itsties to industry-leading health systems
Company Information
Company Status
Publicly-held
Industry
Software
Mailing Address
3165 Millrock Dr. 400
Salt Lake City, UT 84121
USA
Salt Lake City, UT 84121
USA
Phone
Website
Email Address
Not Recorded
Overview
Leaders in Healthcare Data Warehousing, Analytics, and Outcomes Improvement, Health Catalyst (Nasdaq: HCAT) utilizes a late-binding EDW to reduce costs and improve care for managed health populations.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Daniel Burton
Chief Financial Officer
Patrick Nelli
Chief Operating Officer
Paul Horstmeier
President
Thomas Burton
Vice President
Steven Barlow
Vice President
Leslie Falk
Vice President
Kyle Salyers
VP - Engineering
Dale Sanders
VP - General Counsel
Daniel Orenstein
VP - Human Resources
Jeff Selander
VP - Product Management
Linda Llewelyn
VP - Sales
Thomas Leifsen
Browse more venture capital transactions:
Prev: 2/28/2013: MedShape venture capital transaction
Next: 2/28/2013: Zoomingo venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here come from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs